Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.662
Buy
RSI(14)
61.683
Neutral
STOCH(KDJ)(9,3,3)
75.922
Neutral
ATR(14)
1.826
High Vlolatility
CCI(14)
70.251
Neutral
Williams %R
37.573
Buy
TRIX(12,20)
1.018
Sell
StochRSI(14)
0.000
Sell
Search
AtriCure Inc
ATRCAdd to Watchlist
37.760USD
-2.390-5.95%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.92BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-5.95%
5 Days
+7.76%
1 Month
+27.01%
6 Months
+2.25%
Year to Date
-4.55%
1 Year
+9.74%
Key Figures
39.390Open
39.405High
1.31MVolume
LossP/E TTM
92.30P/E Dynamic
--Dividend TTM
2.64%Turnover Ratio
40.150Prev. Close
37.440Low
34.96MTurnover
LossP/E Static
3.94P/B
0.00%Div Yield TTM
-0.74%ROA
43.18052wk High
1.12Volume Ratio
-44.70MNet Profit
49.71MShares
-0.0952EPS TTM
1.27Beta
-0.97%ROE
25.52052wk Low
4.89%Amplitude
77.23%Gross Margin
1.92BMarket Cap
8.73Reward/Risk
2.74%Risk Rate
TradingKey Stock Score of AtriCure Inc
Currency: USD Updated: 2026-07-31Key Insights
AtriCure Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 19 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 48.75.In the medium term, the stock price is expected to trend up.Despite a strong stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
AtriCure Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive+
AtriCure Inc Highlights
StrengthsRisks
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 33.88% year-on-year.
Undervalued
The company’s latest PE is -396.81, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 48.18M shares, decreasing 12.70% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 43.35K shares of this stock.
Analyst Rating
Based on
10
analysts
Buy
Current Rating
48.750
Target Price
+29.10%
Upside Space
AtriCure Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
10
analysts
Buy
Current Rating
48.750
Target Price
+29.10%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
AtriCure Inc
ATRC
10
Medtronic PLC
MDT
34
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Indicators
Moving Average
Indicators
Value
Direction
MA5
39.184
Sell
MA10
36.675
Buy
MA20
35.434
Buy
MA50
31.044
Buy
MA100
29.850
Buy
MA200
33.136
Buy
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
AtriCure Inc Info
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Ticker SymbolATRC
CompanyAtriCure Inc
CEOCarrel (Michael H)
Websitehttps://www.atricure.com
Shareholders
Related Instruments
-1.72%
-0.43%
+0.12%
-0.59%
-0.74%
-6.42%
+0.10%
-0.36%
+1.75%
-0.14%
-2.99%
+1.58%
-0.29%
+0.41%
-1.02%
+0.13%
+0.05%
-0.80%
-0.24%
-0.70%Popular Instruments
52695.700
+317.700 (+0.61%)
28499.600
+338.700 (+1.20%)
7526.900
+51.800 (+0.69%)
14792.000
+43.000 (+0.29%)
63320.000
+468.000 (+0.74%)
6396.400
+31.000 (+0.49%)
78.952
-6.982 (-8.13%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4072.200
+30.770 (+0.76%)
FAQs
What is the current price of AtriCure Inc (ATRC)?
The current price of AtriCure Inc (ATRC) is 37.76.
What is the symbol of AtriCure Inc?
The ticker symbol of AtriCure Inc is ATRC.
What is the 52-week high of AtriCure Inc?
The 52-week high of AtriCure Inc is 43.18.
What is the 52-week low of AtriCure Inc?
The 52-week low of AtriCure Inc is 25.52.
What is the market capitalization of AtriCure Inc?
The market capitalization of AtriCure Inc is 1.88B.
Is AtriCure Inc (ATRC) currently rated as Buy, Hold, or Sell?
According to analysts, AtriCure Inc (ATRC) has an overall rating of Buy, with a price target of 48.75.
What is the Earnings Per Share (EPS TTM) of AtriCure Inc (ATRC)?
The Earnings Per Share (EPS TTM) of AtriCure Inc (ATRC) is -0.24.